Rayna Dyck, MD
Dermatology · Homewood, ALNPI 1093958878
Payments from drug & device makers
Across 549 payments — averaging $130.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$31K
- UCB, Inc.$14K
- Novartis$11K
- AbbVie$6K
- LEO Pharma Inc.$3K
- Arcutis Biotherapeutics, Inc.$2K
- plus $5K from 31 others
What the payments were for
- Consulting fees$27,19538%
- Speaking & faculty fees$25,10035%
- Travel & lodging$7,41510%
- Food & beverage$11,49216%
- Education$2500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 49 | $30,537 |
| UCB, Inc. | 21 | $14,072 |
| Novartis | 63 | $11,183 |
| AbbVie(2 entities) | 147 | $5,782 |
| LEO Pharma Inc. | 47 | $2,609 |
| Arcutis Biotherapeutics, Inc. | 34 | $2,233 |
| Incyte Corporation | 16 | $500 |
| Biofrontera Inc. | 4 | $467 |
| Galderma Laboratories, L.p. | 20 | $414 |
| Revance Therapeutics, Inc. | 6 | $351 |
| Dermavant Sciences, Inc. | 21 | $301 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $283 |
| Johnson & Johnson | 5 | $282 |
| Sun Pharmaceutical Industries Inc. | 15 | $280 |
| Pfizer | 17 | $269 |
| Novo Nordisk | 2 | $234 |
| Almirall LLC | 6 | $231 |
| Mayne Pharma Commercial LLC | 13 | $224 |
| Sanofi | 6 | $157 |
| E.r. Squibb & Sons, L.L.C. | 6 | $143 |
| Metuchen Pharmaceuticals | 1 | $130 |
| Organon | 10 | $118 |
| Dexcom, Inc. | 1 | $118 |
| Amgen | 6 | $110 |
| Pacira Therapeutics, Inc. | 1 | $90 |
| Botanix SB Inc | 3 | $56 |
| Boehringer Ingelheim | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| VYNE Pharmaceuticals Inc. | 2 | $30 |
| Encore Dermatology Inc. | 2 | $27 |
| Mission Pharmacal Company | 2 | $26 |
| Merck | 2 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Sandoz | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,452 in reported general payments places this provider in the 85th percentile of 168 dermatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $176,663 |
| Clobetasol Propionate | 74 | $5,385 |
| Ketoconazole | 128 | $2,131 |
| Clindamycin Phosphate | 27 | $1,589 |
| Metronidazole | 16 | $1,394 |
| Tretinoin | 23 | $1,251 |
| Tacrolimus | 11 | $1,175 |
| Betamethasone Dipropionate | 17 | $912 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 15 | $833 |
| Ammonium Lactate | 32 | $804 |
| ValacyclovirValacyclovir Hcl | 18 | $788 |
| Doxycycline Hyclate | 26 | $757 |
| Mupirocin | 71 | $626 |
| Gentamicin Sulfate | 12 | $603 |
| Desonide | 15 | $532 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Homewood
- Jennifer BaresHomewood$12K
- Vlada GroysmanHoover$7.2M
- Boni ElewskiBirmingham$5.5M
- James KrellBirmingham$4M
- John VanloockMobile$1.4M
- Tiffany MayoBirmingham$1.4M
- Melanie AppellBirmingham$983K
- Julie HarperBirmingham$920K
- Eric BaumGadsden$896K
- Corey HartmanBirmingham$744K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.